微创活检诊断乳腺癌新辅助治疗后病理完全缓解
这项多中心前瞻性试验纳入452例新辅助全身治疗(NST)后影像学确认部分或完全缓解的1-3期乳腺癌患者,398例纳入全分析,评估影像引导真空辅助活检(VAB)诊断乳腺病理完全缓解(pCR-B)的可靠性。VAB单独诊断的假阴性率(FNR)为17.8%,探索性分析显示7G最大针具VAB无假阴性,影像联合VAB可将FNR降至6.2%。
要点
- 影像引导VAB单独诊断pCR-B的假阴性率为17.8%,高于预期。
- 7G最大针具VAB未出现假阴性结果。
- 影像联合VAB可将假阴性率降至6.2%。
核心结论
- 影像引导VAB遗漏残留病变的频率高于预期,在免除乳腺手术前需改进操作与患者选择。
研究设计与样本
- 多中心前瞻性试验纳入452例初诊1-3期、所有生物学亚型的乳腺癌患者,54例退出,398例纳入全分析。
- 所有参与者影像学确认对NST部分或完全缓解,在指南推荐的乳腺手术前接受研究特异性影像引导VAB。
- 主要终点为VAB确认pCR-B的假阴性率(FNR)。
主要发现
- 影像引导VAB单独在208例女性中的37例未检出手术确认的残留肿瘤(FNR 17.8%,95%CI 12.8-23.7%)。
- 37例假阴性中,12例(32.4%)仅为残留DCIS,20例(54.1%)为微小残留肿瘤(<5 mm),25例中19例(76.0%)浸润性癌细胞密度≤10%。
- 37例中19例(51.4%)的假阴性结果可能可以避免。
- 探索性分析显示,使用最大体积针具(7-gauge)进行VAB无假阴性结果。
- 将影像与影像引导VAB结合为单一诊断测试,FNR降至6.2%(95%CI 3.4%-10.5%)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the ability of minimally invasive, image-guided vacuum-assisted biopsy (VAB) to reliably diagnose a pathologic complete response in the breast (pCR-B). SUMMARY BACKGROUND DATA: Neoadjuvant systemic treatment (NST) elicits a pathologic complete response in up to 80% of women with breast cancer. In such cases, breast surgery, the gold standard for confirming pCR-B, may be considered overtreatment. METHODS: This multicenter, prospective trial enrolled 452 women presenting with initial stage 1-3 breast cancer of all biological subtypes. Fifty-four women dropped out; 398 were included in the full analysis. All participants had an imaging-confirmed partial or complete response to NST and underwent study-specific image-guided VAB before guideline-adherent breast surgery. The primary endpoint was the false-negative rate (FNR) of VAB-confirmed pCR-B. RESULTS: Image-guided VAB alone did not detect surgically confirmed residual tumor in 37 of 208 women [FNR, 17.8%; 95% confidence interval (CI), 12.8-23.7%]. Of these 37 women, 12 (32.4%) had residual DCIS only, 20 (54.1%) had minimal residual tumor (<5 mm), and 19 of 25 (76.0%) exhibited invasive cancer cellularity of ≤10%. In 19 of the 37 cases (51.4%), the false-negative result was potentially avoidable. Exploratory analysis showed that performing VAB with the largest needle by volume (7-gauge) resulted in no false-negative results and that combining imaging and image-guided VAB into a single diagnostic test lowered the FNR to 6.2% (95% CI, 3.4%-10.5%). CONCLUSIONS: Image-guided VAB missed residual disease more often than expected. Refinements in procedure and patient selection seem possible and necessary before omitting breast surgery.
引用
- Heil J, Pfob A, Sinn HP, et al. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03. Ann Surg. 2022. PMID: 32657944. doi:10.1097/SLA.0000000000004246
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。